Literature DB >> 22956391

Role of nuclear factor-ĸB in breast and colorectal cancer.

Adeel Zubair1, Marianne Frieri.   

Abstract

The purpose of this review article is to highlight articles and new research regarding the link between NF-ĸB and several cancers. This review presents the most up-to-date NF-ĸB research and how it links this important transcription factor with hematology and oncology. It was written by conducting a thorough search of Pubmed as well as several journals such as Cancer, Nature, Science, Cell and those of one of the authors. The articles relating to the link between NF-ĸB and cancer were used to write this review. The results of this study clarified that there is a critical link between NF-ĸB and cancer. NF-ĸB has often been implicated in a variety of different diseases and it plays a variety of roles in cell survival, differentiation, and proliferation of cells. In cancer, NF-ĸB plays a pivotal role by facilitating oncogenesis as well as metastasis. A thorough understanding of NF-ĸB and its role in cancer can lead to future studies and drug development which could provide a novel option in the treatment of this disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22956391     DOI: 10.1007/s11882-012-0300-5

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  69 in total

Review 1.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

Authors:  M Karin; Y Ben-Neriah
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 2.  NF-κB, the first quarter-century: remarkable progress and outstanding questions.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Genes Dev       Date:  2012-02-01       Impact factor: 11.361

Review 3.  Transcriptional regulation via the NF-kappaB signaling module.

Authors:  A Hoffmann; G Natoli; G Ghosh
Journal:  Oncogene       Date:  2006-10-30       Impact factor: 9.867

4.  Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl.

Authors:  Ruby John Anto; Asok Mukhopadhyay; Kate Denning; Bharat B Aggarwal
Journal:  Carcinogenesis       Date:  2002-01       Impact factor: 4.944

Review 5.  NF-κB in immunobiology.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Cell Res       Date:  2011-01-18       Impact factor: 25.617

6.  PPAR-gamma is expressed and NF-kB pathway is activated and correlates positively with COX-2 expression in stromal myofibroblasts surrounding colon adenocarcinomas.

Authors:  Gerasimos P Vandoros; Panagiotis A Konstantinopoulos; Georgia Sotiropoulou-Bonikou; Athina Kominea; Georgios I Papachristou; Michalis V Karamouzis; Maria Gkermpesi; Ioannis Varakis; Athanasios G Papavassiliou
Journal:  J Cancer Res Clin Oncol       Date:  2005-10-08       Impact factor: 4.553

Review 7.  NF-κB, inflammation, and metabolic disease.

Authors:  Rebecca G Baker; Matthew S Hayden; Sankar Ghosh
Journal:  Cell Metab       Date:  2011-01-05       Impact factor: 27.287

8.  Human mesothelioma samples overexpress both cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (NOS2): in vitro antiproliferative effects of a COX-2 inhibitor.

Authors:  A Marrogi; H I Pass; M Khan; L J Metheny-Barlow; C C Harris; B I Gerwin
Journal:  Cancer Res       Date:  2000-07-15       Impact factor: 12.701

9.  ErbB receptor tyrosine kinase/NF-κB signaling controls mammosphere formation in human breast cancer.

Authors:  Kunihiko Hinohara; Seiichiro Kobayashi; Hajime Kanauchi; Seiichiro Shimizu; Kotoe Nishioka; Ei-ichi Tsuji; Kei-ichiro Tada; Kazuo Umezawa; Masaki Mori; Toshihisa Ogawa; Jun-ichiro Inoue; Arinobu Tojo; Noriko Gotoh
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-05       Impact factor: 11.205

10.  NF-kappa B inhibition markedly enhances sensitivity of resistant breast cancer tumor cells to tamoxifen.

Authors:  L A deGraffenried; B Chandrasekar; W E Friedrichs; E Donzis; J Silva; M Hidalgo; J W Freeman; G R Weiss
Journal:  Ann Oncol       Date:  2004-06       Impact factor: 32.976

View more
  32 in total

1.  Expression of NF-κB-inducing kinase in breast carcinoma tissue and its clinical significance.

Authors:  Xuliang Zhang; Yong Wang; Zheyu Mao; Danqing Huang; Junwei Zhou; Xudong Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

2.  Cyclodextrin mediated delivery of NF-κB and SRF siRNA reduces the invasion potential of prostate cancer cells in vitro.

Authors:  J C Evans; J McCarthy; C Torres-Fuentes; J F Cryan; J Ogier; R Darcy; R W Watson; C M O'Driscoll
Journal:  Gene Ther       Date:  2015-05-25       Impact factor: 5.250

Review 3.  Cancer-promoting effects of microbial dysbiosis.

Authors:  Amy M Sheflin; Alyssa K Whitney; Tiffany L Weir
Journal:  Curr Oncol Rep       Date:  2014-10       Impact factor: 5.075

Review 4.  Nuclear factor kappa B role in inflammation associated gastrointestinal malignancies.

Authors:  Sahil Gambhir; Dinesh Vyas; Michael Hollis; Apporva Aekka; Arpita Vyas
Journal:  World J Gastroenterol       Date:  2015-03-21       Impact factor: 5.742

5.  Genetic polymorphisms of NFκB1-94ins/delATTG and NFκBIA-881A/G genes in Egyptian patients with colorectal cancer.

Authors:  Mohamed Ragab Youssef; Zeinab Ibraheim Attia; Rizk Ahmed El-Baz; Sameh Roshdy; Ahmad Settin
Journal:  Fam Cancer       Date:  2017-10       Impact factor: 2.375

Review 6.  Antibody-based therapeutics for the treatment of human B cell malignancies.

Authors:  Sivasubramanian Baskar; Natarajan Muthusamy
Journal:  Curr Allergy Asthma Rep       Date:  2013-02       Impact factor: 4.806

7.  Serine-arginine protein kinase 1 is associated with breast cancer progression and poor patient survival.

Authors:  Xing-hua Li; Jun-wei Song; Jun-ling Liu; Shu Wu; Le-shi Wang; Li-yun Gong; Xi Lin
Journal:  Med Oncol       Date:  2014-06-25       Impact factor: 3.064

8.  Celecoxib and fish oil: a combination strategy for decreased inflammatory mediators in early stages of experimental mammary cancer.

Authors:  Anjana Kumari Negi; Archana Bhatnagar; Navneet Agnihotri
Journal:  Inflammopharmacology       Date:  2016-01-09       Impact factor: 4.473

Review 9.  MicroRNAs as biomarkers and prospective therapeutic targets in colon and pancreatic cancers.

Authors:  Ganji Purnachandra Nagaraju; Appiya Santharam Madanraj; Sheik Aliya; Balney Rajitha; Olatunji Boladale Alese; Ekamber Kariali; Afroz Alam; Bassel F El-Rayes
Journal:  Tumour Biol       Date:  2015-11-04

10.  Suppression of inflammatory cascade is implicated in methyl amooranin-mediated inhibition of experimental mammary carcinogenesis.

Authors:  Animesh Mandal; Deepak Bhatia; Anupam Bishayee
Journal:  Mol Carcinog       Date:  2013-07-12       Impact factor: 4.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.